Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection

Published:2016-06-14 Issue: Volume:6 Page:
ISSN:2235-2988
Container-title:Frontiers in Cellular and Infection Microbiology
language:
Short-container-title:Front. Cell. Infect. Microbiol.

Author:

Boianelli Alessandro,Sharma-Chawla Niharika,Bruder Dunja,Hernandez-Vargas Esteban A.

Funder

Bundesministerium für Bildung und Forschung

Human Frontier Science Program

Deutsche Forschungsgemeinschaft

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference59 articles.

1. Early administration of oral oseltamivir increases the benefits of influenza treatment;Aoki;J. Antimicrob. Chemother.,2003

2. Kinetics of influenza A virus infection in humans;Baccam;J. Virol.,2006

3. A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead;Beauchemin;BMC Public Health,2011

4. Modeling influenza virus infection: a roadmap for influenza research;Boianelli;Viruses,2015

5. Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics;Canini;J. Virol.,2011

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamical study of SARS-CoV-2 mathematical models under antiviral treatments;Mathematical Modelling, Simulations, and AI for Emergent Pandemic Diseases;2023

2. Closing the loop in personalized medicine;Feedback Control for Personalized Medicine;2022

3. Development and Effects of Influenza Antiviral Drugs;Molecules;2021-02-04

4. Oseltamivir—Current Dosing Recommendations Reduce the Therapeutic Benefit in Patients With Mild to Moderate Renal Function and/or Large Body Mass: A Review of the Literature With Recommendations to Optimize Dosing, Including the Use of Therapeutic Drug Monitoring;Therapeutic Drug Monitoring;2021-02

5. Offset-free MPC strategy for nonzero regulation of linear impulsive systems;ISA Transactions;2020-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3